title: General surgery considerations in the era of mechanical circulatory assist devices.
abstract: Much of the success of left ventricular assist devices (LVAD) can be attributed to the second-generation HeartMate II (Thoratec, Pleasanton, CA, USA), which is the most commonly used device to date. The latest generation of LVADs is currently undergoing clinical trials worldwide. Developers have focused on improving the limitations of the second generation with emphasis on enhancing efficiency further, decreasing complications, and increasing ease of implantability. Clinical management of a patient with an LVAD is also an excellent example of the multidisciplinary approach of care that is undoubtedly the future of medicine.
authors.affiliation: Department of Cardiovascular Surgery, Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, 6550 Fannin Street, Suite 1401, Houston, TX 77030, USA.
authors.forename: Limael E
authors.initials: LE
authors.lastname: Rodriguez
authors.forename: Erik E
authors.initials: EE
authors.lastname: Suarez
authors.forename: Matthias
authors.initials: M
authors.lastname: Loebe
authors.forename: Brian A
authors.initials: BA
authors.lastname: Bruckner
mesh_terms: D017558:Elective Surgical Procedures / Q000401:mortality; D004867:Equipment Design; D006333:Heart Failure / Q000453:epidemiology* / Q000628:therapy; D006353:Heart-Assist Devices; D006801:Humans; D010348:Patient Care Team; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors
keywords: General surgery; LVAD; Left ventricular assist device; Mechanical circulatory support; Noncardiac surgery